Speakers
Alfred Berkeley, President
The Nasdaq Stock Market
Karen Bernstein, Editor-in-Chief
Bio Century
Pascal Brandys, Chairman and Chief Executive Officer
GENSET S.A.
Jerry Brown, Mayor
City of Oakland
Mark Edwards, Managing Director
Recombinant Capital
David Gollaher, President & CEO
California Healthcare Institute
Dr. Jane Henney, Commissioner
Food and Drug Administration
Mark Jensen, Managing Partner, Silicon Valley
Arthur Andersen LLP
Vaughn Kailian, President and CEO
COR Therapeutics, Inc.
Vera Kallmeyer, Principal
Veritas Venture Partners LLC
Rich Karlgaard, Publisher
Forbes
David Kingsbury, Chief Information Officer
Chiron Corporation
Michael Knapp, Founder and VP, Science Technology
Caliper Technologies
Dr. David Lawrence, Chairman and CEO
Kaiser Foundation Health Plan, Inc.
W. Michael Long, CEO
Healtheon
Chuck Ludlam, V.P. Government Affairs
Biotechnology Industry Organization
John Martin, President, CEO, and Director
Gilead Sciences, Inc.
Regis McKenna, Chairman
The McKenna Group Walter Moore, V.P. Government Affairs
Genentech Corp.
Luther Nussbaum, CEO
First Consulting Group, Inc.
Ed Penhoet, Dean
UC Berkeley, School of Public Health
William Rastetter, CEO
IDEC Pharmaceuticals
Dr. J. Leighton Read, Chairman & CEO
Aviron
Arthur Reidel, President & CEO
Pharsight
David Robinson, Chairman, President, and CEO
Ligand Pharmaceuticals, Inc.
Jim Scopa, Managing Director Healthcare Group
Deutsche Banc Alex.Brown
Randy Scott, President, CSO and Secretary
Incyte Pharmaceuticals
Lewis Shuster, President and Chief Operating Officer
Pharmacopeia Laboratories
Deborah Smeltzer, Chief Financial Officer
Genset
Laura Tyson, Dean, Haas School of Business
UC Berkeley
Richard van den Broek, Senior Analyst
Hambrecht & Quist
Kurt von Emster, Portfolio Manager
Franklin Advisors
Wendell Wierenga, Senior VP, Worldwide
Preclinical R&D and Technologies
Thomas Wiggans, Chief Executive Officer
Connetics Corporation
Jim Woody, President
Roche Bioscience
